Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001458|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : March 12, 2021
An important mission of the National Institutes of Health (NIH) is to develop and carry out research studies designed to improve understanding of disease processes and treatments.
Clinical research continues to become more focused on specific diseases and the signs and symptoms of diseases in specific groups of people and patients.
This study is designed to permit inpatient evaluation and care of patients with heart disease who do not qualify to participate in research studies being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). These patients are valuable to the Cardiology Branch of the NHLBI because they help to improve training and experience of its researchers.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||7829 participants|
|Official Title:||Diagnosis and Treatment of Patients With Heart and Vascular Disease (Training Protocol)|
|Actual Study Start Date :||January 1, 1995|
|Actual Primary Completion Date :||July 28, 2020|
|Actual Study Completion Date :||July 28, 2020|
subjects with cardiovascular symptoms or known disease.
- training of staff [ Time Frame: 20 years ]staff becomes familiar or proficient in cardiovascular diagnostic studies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001458
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Alessandra Brofferio, M.D.||National Heart, Lung, and Blood Institute (NHLBI)|